rapid-acting antidepressants

rapid-acting antidepressants

In a Surprising Clinical Trial, Ketamine’s Antidepressant Effects Lasted Longer
Carefully designed, exquisitely controlled experiments sometimes don't produce the result predicted in advance—the research “hypothesis” that is the starting point... Read More
Over Two Decades, 90 BBRF Grants Helped Build a Scientific Foundation for the First Rapid-Acting Antidepressants
In the spring of 2019, The Food and Drug Administration granted approval for two breakthrough medicines that act rapidly to... Read More
Study: Ketamine Restores Neural Connection Points Lost in Stress & Depression
Researchers led by 2013 BBRF Young Investigator Conor Liston, M.D., Ph.D. , have just reported a surprising finding about the... Read More
Advisory Panel Recommends FDA Approval of Esketamine , with New Mechanism to Treat Resistant Depression & Suicidal Thinking
On February 12th, an FDA advisory panel recommended overwhelmingly that the agency approve a drug called esketamine for the rapid... Read More
Seeking the Optimal Dose for Ketamine’s Short-Term Rapid Antidepressant Effects
Although many studies in recent years have provided evidence that ketamine, an anesthetic drug, can provide rapid relief to people... Read More